Literature DB >> 6416910

Polyol pathway activity and myo-inositol metabolism. A suggested relationship in the pathogenesis of diabetic neuropathy.

D Finegold, S A Lattimer, S Nolle, M Bernstein, D A Greene.   

Abstract

Two major metabolic perturbations, increased polyol (sorbitol) pathway activity and reduced tissue myo-inositol content, are induced in peripheral nerve by hyperglycemia. Although they are commonly invoked as alternative biochemical pathogenetic mechanisms for diabetic neuropathy, their possible interrelationship has never been adequately explored. Therefore, we studied the effect of polyol pathway blockade with sorbinil, a specific inhibitor of aldose reductase, on nerve myo-inositol content in acutely streptozotocin-diabetic rats. Sorbinil administration completely prevented the fall in nerve myo-inositol, thereby implicating increased polyol pathway activity as a likely factor in the fall in nerve myo-inositol content in experimental diabetes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6416910     DOI: 10.2337/diab.32.11.988

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  40 in total

1.  Novel insights into the structural requirements for the design of selective and specific aldose reductase inhibitors.

Authors:  Hirdesh Kumar; Anup Shah; M Elizabeth Sobhia
Journal:  J Mol Model       Date:  2011-08-12       Impact factor: 1.810

2.  Measuring brain uptake and incorporation into brain phosphatidylinositol of plasma myo-[2H6]inositol in unanesthetized rats: an approach to estimate in vivo brain phosphatidylinositol turnover.

Authors:  Kaizong Ma; Joseph Deutsch; Nelly E Villacreses; Thad A Rosenberger; Stanley I Rapoport; H Umesha Shetty
Journal:  Neurochem Res       Date:  2006-06-22       Impact factor: 3.996

3.  Effect of treatment of high fat fed/low dose streptozotocin-diabetic rats with Ilepatril on vascular and neural complications.

Authors:  Eric P Davidson; Lawrence J Coppey; Amey Holmes; Brian Dake; Mark A Yorek
Journal:  Eur J Pharmacol       Date:  2011-07-28       Impact factor: 4.432

4.  Role of the effect of inhibition of neutral endopeptidase on vascular and neural complications in streptozotocin-induced diabetic rats.

Authors:  Christine L Oltman; Eric P Davidson; Lawrence J Coppey; Travis L Kleinschmidt; Brian Dake; Mark A Yorek
Journal:  Eur J Pharmacol       Date:  2010-10-30       Impact factor: 4.432

5.  Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens.

Authors:  A Y Lee; S K Chung; S S Chung
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

Review 6.  Diabetic neuropathies. Current concepts in prevention and treatment.

Authors:  J D Ward
Journal:  Drugs       Date:  1986-09       Impact factor: 9.546

7.  Peripheral nerve function in relation to quality of metabolic control in diabetes.

Authors:  F W Bertelsmann; J J Heimans; J C van Rooy; C Popp-Snijders; E A van der Veen
Journal:  J Neurol       Date:  1987-06       Impact factor: 4.849

8.  Pattern of myelinated fibre loss in the sural nerve in neuropathy related to type 1 (insulin-dependent) diabetes.

Authors:  J G Llewelyn; P K Thomas; S G Gilbey; P J Watkins; J R Muddle
Journal:  Diabetologia       Date:  1988-03       Impact factor: 10.122

9.  myo-Inositol and sorbitol in erythrocytes from diabetic patients before and after sorbinil treatment.

Authors:  C Popp-Snijders; M Z Lomecky-Janousek; J A Schouten; E A van der Veen
Journal:  Diabetologia       Date:  1984-11       Impact factor: 10.122

10.  Sorbinil does not prevent hyperfiltration, elevated ultrafiltration pressure and albuminuria in streptozotocin-diabetic rats.

Authors:  A Körner; G Celsi; A C Eklöf; T Linné; B Persson; A Aperia
Journal:  Diabetologia       Date:  1992-05       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.